VRS
RPTX

Virginia Retirement Systems’s Repare Therapeutics RPTX Stock Holding History

Virginia Retirement Systems’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-11,400
Closed -$168K – 1201
2022
Q4 		$168K Sell
11,400
-2,600
-19% -$38.9K ﹤0.01% 1070
2022
Q3 		$170K Buy
+14,000
New +$180K ﹤0.01% 1076

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Virginia Retirement Systems's RPTX Position: Q1 2023 in Review

Virginia Retirement Systems sold out of Repare Therapeutics (RPTX) in Q1 2023, closing a stake of 11,400 shares — an estimated $168K sold.

Virginia Retirement Systems first reported a position in RPTX in Q3 2022 and held it in 2 quarters. The position peaked at $170K in Q3 2022. 77 funds tracked by Wall St. Rank hold RPTX as of Q1 2023.

  • Virginia Retirement Systems reported no remaining Repare Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Virginia Retirement Systems sold 11,400 Repare Therapeutics shares in Q1 2023, an estimated $168K.
  • Virginia Retirement Systems first reported a position in Repare Therapeutics in Q3 2022 and held it in 2 quarters.
  • Virginia Retirement Systems's Repare Therapeutics position peaked at $170K in Q3 2022.
  • 77 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2023.

Based on Virginia Retirement Systems's 13F filing for Q1 2023, filed 11 Jul 2023.